Update on Epilepsy: History, Classification, & Treatment Options

Ames, IA US
August 23, 2017

Mary Greeley Medical Center Grand Rounds is a multi-disciplinary clinical activity which serves to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public or the profession.  

Target Audience

Physicians, mid-level providers, nurses and healthcare administrators.

Learning Objectives

  1. Discuss the history of epileptic drugs & current recommendations.
  2. Identify tests used to diagnose epilepsy.
  3. Explore other treatment options for epilepsy.

Speaker(s)

David Moore, MD
Neurology, McFarland Clinic

Disclosures

Speaker(s)

  • Dr. Moore discloses the following financial relationship with commercial entities:
    • An open-label, multicenter study with an extension phase to evaluate the safety, tolerability, and exposure-efficacy relationship of perampanel oral suspension when administered as an adjunctive therapy in pediatric subjects (age 4 to less than 12 years) with inadequately controlled partial-onset seizures or primary generalized tonic-clonic seizures (E2007-G000-311) Principal Investigator (Dec 2016 - present).
    • A multicenter, double blind, randomized, placebo-controlled trial with an open-label extension phase of perampanel as adjunctive treatment in subjects at least 2 years of age with inadequately controlled seizures associated with Lennox-Gastaut Syndrome (E2007-G000-338) Principal Investigator (Dec 2016  - present).
    • An open-label, multicenter, safety and pharmacokinetic study of YKP3089 as adjunctive therapy in subjects with partial onset seizure (YKP3089C021) Principal Investigator (Nov 2016 - present).
    • ​​​​​​​A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P) in children and young adults with Dravet Syndrome (GWEP1424) Principal Investigator (May 2016 - present).
    • A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox-Gastaut Syndrome in children and adults (GWEP1423) Principal Investigator (May 2016 - Jan 2017).

CME Committee

  • No member of the Mary Greeley Medical Center CME Committee who planned this activity has any financial relationship to disclose relating to the content. 

This program is supported by gifts to the Mary Greeley Medical Center Foundation from Mary Greeley Medical Center, McFarland Clinic, First American Bank, and Green Hills Health Care Center. The content and selection of speaker(s) is the responsibility of the Mary Greeley Medical Center for Continuing Medical Education Committee and not the sponsors of this program.

    Course summary
    Available credit: 
    • 1.00 AOA Category 2­A
    Course opens: 
    08/23/2017
    Course expires: 
    08/23/2017
    Event starts: 
    08/23/2017 - 12:00pm
    Event ends: 
    08/23/2017 - 1:00pm
    Cost:
    $0.00
    Rating: 
    0
    Mary Greeley Medical Center
    Bessie Myers Auditorium
    1111 Duff Avenue
    Ames, IA 50010
    United States

    Continuing Education Credit

    • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

    Available Credit

    • 1.00 AOA Category 2­A

    Accreditation Period

    Course opens: 
    08/23/2017
    Course expires: 
    08/23/2017

    Price

    Cost:
    $0.00
    Please login or Create an Account to take this course.